Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3420)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
489
Price
$533.24
Total Value
$260.76K
Shares Held After
326,994
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$531.22
Total Value
$212.49K
Shares Held After
327,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$529.80
Total Value
$402.64K
Shares Held After
327,883
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
874
Price
$528.91
Total Value
$462.26K
Shares Held After
328,643
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,211
Price
$527.82
Total Value
$639.19K
Shares Held After
329,517
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,610
Price
$526.84
Total Value
$1.38M
Shares Held After
330,728
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
485
Price
$526.04
Total Value
$255.13K
Shares Held After
333,338
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$524.27
Total Value
$62.91K
Shares Held After
333,823
% of Holdings
0.0%
Greenland Mines Ltd (GRML)
Sawyer Jason David — Director
Shares
240,000
Price
$0.23
Total Value
$55.94K
Shares Held After
240,000
% of Holdings
100.0%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
120,582
Price
$9.55
Total Value
$1.15M
Shares Held After
17,098,479
% of Holdings
0.7%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
213,702
Price
$22.12
Total Value
$4.73M
Shares Held After
812,058
% of Holdings
20.8%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
278,698
Price
$21.72
Total Value
$6.05M
Shares Held After
1,025,760
% of Holdings
21.4%
Mineralys Therapeutics, Inc. (MLYS)
Warren Eric — Chief Commercial Officer
Shares
7,438
Price
$26.87
Total Value
$199.89K
Shares Held After
38,400
% of Holdings
16.2%
Rani Therapeutics Holdings, Inc. (RANI)
IMRAN MIR A — Director
Shares
36,000
Price
$0.69
Total Value
$24.84K
Shares Held After
2,119,334
% of Holdings
1.7%
Acrivon Therapeutics, Inc. (ACRV)
Miller Mary — Chief Legal Officer
Shares
573
Price
$1.76
Total Value
$1.01K
Shares Held After
82,194
% of Holdings
0.7%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research&Development
Shares
3,500
Price
$80.59
Total Value
$282.06K
Shares Held After
153,902
% of Holdings
2.2%
FORUM MARKETS Inc (FRMM)
Lomashuk Konstantin — 10% Owner
Shares
250,000
Price
$6.00
Total Value
$1.50M
Shares Held After
1,226,638
% of Holdings
16.9%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
556
Price
$80.66
Total Value
$44.85K
Shares Held After
701,477
% of Holdings
0.1%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
74,444
Price
$79.98
Total Value
$5.95M
Shares Held After
702,033
% of Holdings
9.6%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
2,340
Price
$320.06
Total Value
$748.94K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
15,807
Price
$319.29
Total Value
$5.05M
Shares Held After
2,340
% of Holdings
87.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
7,842
Price
$318.41
Total Value
$2.50M
Shares Held After
18,147
% of Holdings
30.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
20,029
Price
$316.91
Total Value
$6.35M
Shares Held After
25,989
% of Holdings
43.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
15,379
Price
$316.26
Total Value
$4.86M
Shares Held After
46,018
% of Holdings
25.0%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
1,478
Price
$6.53
Total Value
$9.65K
Shares Held After
492,079
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
839
Price
$536.37
Total Value
$450.02K
Shares Held After
324,443
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
341
Price
$535.44
Total Value
$182.59K
Shares Held After
325,282
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,760
Price
$534.61
Total Value
$940.92K
Shares Held After
325,623
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$533.58
Total Value
$341.49K
Shares Held After
327,383
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$532.47
Total Value
$191.69K
Shares Held After
328,023
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,605
Price
$531.52
Total Value
$1.38M
Shares Held After
328,383
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,926
Price
$530.50
Total Value
$1.02M
Shares Held After
330,988
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
509
Price
$529.55
Total Value
$269.54K
Shares Held After
332,914
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$527.46
Total Value
$126.59K
Shares Held After
333,423
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$526.24
Total Value
$84.20K
Shares Held After
333,663
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$524.37
Total Value
$62.92K
Shares Held After
333,823
% of Holdings
0.0%
MeiraGTx Holdings plc (MGTX)
Giroux Richard — CFO&COO
Shares
56,000
Price
$12.51
Total Value
$700.56K
Shares Held After
908,530
% of Holdings
5.8%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
2,975
Price
$2.44
Total Value
$7.26K
Shares Held After
2,858,935
% of Holdings
0.1%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
3,596
Price
$79.55
Total Value
$286.07K
Shares Held After
776,477
% of Holdings
0.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
280
Price
$318.30
Total Value
$89.12K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
523
Price
$316.14
Total Value
$165.34K
Shares Held After
280
% of Holdings
65.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,512
Price
$315.26
Total Value
$476.68K
Shares Held After
803
% of Holdings
65.3%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,850
Price
$313.91
Total Value
$580.73K
Shares Held After
2,315
% of Holdings
44.4%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
14,326
Price
$312.96
Total Value
$4.48M
Shares Held After
4,165
% of Holdings
77.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
15,499
Price
$312.29
Total Value
$4.84M
Shares Held After
18,491
% of Holdings
45.6%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
2,907
Price
$311.80
Total Value
$906.39K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
6,273
Price
$310.75
Total Value
$1.95M
Shares Held After
2,907
% of Holdings
68.3%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
5,146
Price
$310.08
Total Value
$1.60M
Shares Held After
9,180
% of Holdings
35.9%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
2,915
Price
$31.71
Total Value
$92.43K
Shares Held After
24,353
% of Holdings
10.7%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
31,885
Price
$31.05
Total Value
$990.03K
Shares Held After
27,268
% of Holdings
53.9%
Showing 151–200 of 3420 transactions (page 4 of 69)